Manufacturing Establishments1
FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.
Rising Pharma Holdings, Inc.
650884781
Products3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CHLORZOXAZONE
Product Details
CHLORZOXAZONE
Product Details
CHLORZOXAZONE
Product Details
Drug Labeling Information
Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.
DESCRIPTION SECTION
For Painful Musculoskeletal Conditions
PRESCRIBING INFORMATION
DESCRIPTION
Each 375 mg Chlorzoxazone tablet contains: Chlorzoxazone USP 375 mg.
Each 500 mg Chlorzoxazone tablet contains: Chlorzoxazone USP 500 mg.
Each 750 mg Chlorzoxazone tablet contains: Chlorzoxazone USP 750 mg.
Chemical Name: 5-Chloro-2-benzoxazolinone.
Structural Formula:
Molecular Formula: C7H4CINO2
Molecular Weight: 169.56
Chlorzoxazone USP is a white or practically white, practically odorless, crystalline powder. Chlorzoxazone is slightly soluble in water; sparingly soluble in alcohol, in isopropyl alcohol, and in methanol; soluble in solutions of alkali hydroxides and ammonia.
Inactive ingredients: anhydrous lactose, croscarmellose sodium, docusate sodium with sodium benzoate, magnesium stearate, microcrystalline cellulose and pregelatinized maize starch.
FDA approved dissolution test specifications differ from USP.